Keep the pressure on for more transparency of clinical trials on endometriosis
OA: diamond
CC0
⤵ 5 in-corpus citations
AI-generated summary
This paper advocates for increased transparency in clinical trials concerning endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (5)
- A call for more transparency of registered clinical trials on endometriosis via openalex
- Lack of transparency of clinical trials on endometriosis via openalex
- 'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis via openalex
- W1999738933 via openalex
- W2034731527 via openalex
Cited by (5)
- Bidirectional Mendelian Randomization and Single‑Cell RNA Sequencing Reveal an NK Cell-Mediated Causal Link Between Endometriosis and Endometrial Cancer 2026
- Epidemiologic Factors Associated with Endometriosis in East Asia 2019
- Molecular Characteristics of the Endometrium in Uterine Adenomyosis and Its Biochemical Microenvironment 2017
- Endometriosis and possible inflammation markers 2015
- Epithelial-to-mesenchymal transition in the development of adenomyosis 2015
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK